Holen Sie sich die Stockscreener-App
2.90
7.01%
0.19
Handel nachbörslich:
2.90
Schlusskurs vom Vortag:
$2.71
Offen:
$2.67
24-Stunden-Volumen:
277.92K
Relative Volume:
0.39
Marktkapitalisierung:
$204.08M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-1.9333
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
+1.75%
1M Leistung:
-7.35%
6M Leistung:
-24.48%
1J Leistung:
-64.76%
1-Tages-Spanne:
$2.65
$2.90
1-Wochen-Bereich:
$2.61
$2.92
52-Wochen-Spanne:
$2.515
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.90 | 190.71M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
287.65 | 46.89B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.87 | 16.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.03 | 12.64B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.04 | 8.03B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.62 | 6.90B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
What indicators show strength in Health Catalyst Inc.2025 Trading Volume Trends & Daily Chart Pattern Signal Reports - newser.com
Is Health Catalyst Inc. stock affected by interest rate hikesJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - newser.com
What moving averages say about Health Catalyst Inc.2025 Big Picture & Reliable Intraday Trade Plans - newser.com
Backtesting results for Health Catalyst Inc. trading strategiesJuly 2025 Gainers & Safe Entry Trade Signal Reports - newser.com
What does recent volatility data suggest for Health Catalyst Inc.Weekly Volume Report & Verified Stock Trade Ideas - newser.com
Health Catalyst Inc. stock trend outlook and recovery pathJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
Health Catalyst Inc. recovery potential after sell offMarket Movement Recap & Free Technical Pattern Based Buy Signals - newser.com
Will breakout in Health Catalyst Inc. lead to full recoveryJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Upland Software, Health Catalyst, SoundHound AI, BILL, and DigitalOcean Stocks Trade Down, What You Need To Know - Yahoo Finance
How moving averages guide Health Catalyst Inc. tradingStock Surge & Breakout Confirmation Trade Signals - newser.com
Can you recover from losses in Health Catalyst Inc.2025 Top Gainers & Smart Allocation Stock Tips - newser.com
Should I hold or sell Health Catalyst Inc. stock in 2025Portfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Does Health Catalyst Inc. (2YP) stock trade below intrinsic valuePortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com
Will Health Catalyst Inc. (2YP) stock keep high P E multiplesTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Is Health Catalyst Inc. stock ready for a breakoutWeekly Stock Summary & Expert Curated Trade Setup Alerts - newser.com
Should you wait for a breakout in Health Catalyst Inc.2025 Price Action Summary & Step-by-Step Trade Execution Guides - newser.com
Best data tools to analyze Health Catalyst Inc. stock2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - newser.com
Best Places to Work 2025 - Modern Healthcare
Is Health Catalyst Inc. (2YP) stock protected from inflationWeekly Investment Summary & Consistent Income Trade Ideas - newser.com
Keybanc Lowers Price Target for Health Catalyst (HCAT) | HCAT St - GuruFocus
HCAT: Evercore ISI Group Lowers Price Target for Health Catalyst - GuruFocus
Population Health Management Market Size, Potential Scope 2032 - openPR.com
Health Catalyst, Upstart, ON24, Semrush, and Flywire Shares Plummet, What You Need To Know - Barchart.com
Health Catalyst (HCAT) Receives Neutral Rating from Cantor Fitzg - GuruFocus
How to integrate Health Catalyst Inc. into portfolio analysis toolsInflation Watch & Real-Time Buy Signal Alerts - newser.com
Historical volatility pattern of Health Catalyst Inc. visualizedPortfolio Risk Report & Growth Focused Stock Pick Reports - newser.com
What analysts say about Health Catalyst Inc stockReal Estate Investment Trusts & Superior Capital Investment - earlytimes.in
News impact scoring models applied to Health Catalyst Inc.2025 Year in Review & Proven Capital Preservation Tips - newser.com
Intraday pattern recognizer results for Health Catalyst Inc.July 2025 Momentum & Weekly Market Pulse Alerts - newser.com
What analysts say about Health Catalyst Inc 2YP stockResistance Zone Identification & Small Budget Big Profits - Early Times
What drives Health Catalyst Inc stock priceEarnings Revision Updates & Low Risk Trading Plans - earlytimes.in
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.86%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):